# FDA Inspection 1062143 - Vitalant - August 02, 2018

Source: https://www.keypedia.com/records/fda_inspections/vitalant/0a6a4879-ef9e-4e01-b53e-ecd9ccee7920
Source feed: FDA_Inspections

> FDA Inspection 1062143 for Vitalant on August 02, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062143
- Company Name: Vitalant
- Inspection Date: 2018-08-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1278509 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/vitalant/4b9c8de6-0484-45f2-a892-d587e69b3aac)
- [FDA Inspection 1278509 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/vitalant/9745706b-f504-43c5-9b41-5dee1e2f872a)
- [FDA Inspection 1199067 - 2023-02-24](https://www.keypedia.com/records/fda_inspections/vitalant/d5cf9fa2-9848-4c8a-8b59-40aea83bc1f2)
- [FDA Inspection 1199067 - 2023-02-24](https://www.keypedia.com/records/fda_inspections/vitalant/4424a248-bdcd-4d09-bb77-b577d8d8ab72)
- [FDA Inspection 965393 - 2016-04-07](https://www.keypedia.com/records/fda_inspections/vitalant/8d0df0e5-3e17-4395-976a-b381d24a049c)

Company: https://www.keypedia.com/companies/vitalant/28422953-5ae2-4883-b14d-0ca363c4e083

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d